Barclays Increases DaVita (NYSE:DVA) Price Target to $150.00

DaVita (NYSE:DVA) had its target price boosted by analysts at Barclays from $133.00 to $150.00 in a report released on Monday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s target price suggests a potential upside of 8.86% from the stock’s current price.

A number of other brokerages have also commented on DVA. TheStreet raised DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. StockNews.com upgraded DaVita from a “buy” rating to a “strong-buy” rating in a report on Thursday, April 25th. UBS Group boosted their price objective on shares of DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, February 14th. Finally, Truist Financial raised their target price on shares of DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a research note on Tuesday, February 20th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, DaVita has an average rating of “Moderate Buy” and a consensus price target of $121.33.

DaVita Price Performance

Shares of DVA opened at $137.79 on Monday. The company has a debt-to-equity ratio of 7.95, a quick ratio of 1.37 and a current ratio of 1.43. The firm has a market cap of $12.08 billion, a PE ratio of 15.66, a PEG ratio of 1.17 and a beta of 1.04. The firm’s 50 day moving average price is $134.15 and its 200 day moving average price is $113.89. DaVita has a twelve month low of $71.51 and a twelve month high of $145.04.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.95 by $0.43. The business had revenue of $3.07 billion for the quarter, compared to the consensus estimate of $3.03 billion. DaVita had a net margin of 6.61% and a return on equity of 68.52%. DaVita’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.58 EPS. As a group, research analysts expect that DaVita will post 9.49 EPS for the current fiscal year.

Insider Transactions at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 11,285 shares of the stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $120.73, for a total value of $1,362,438.05. Following the completion of the sale, the insider now directly owns 81,297 shares of the company’s stock, valued at approximately $9,814,986.81. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, insider James O. Hearty sold 26,164 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $119.64, for a total transaction of $3,130,260.96. Following the sale, the insider now directly owns 20,264 shares in the company, valued at $2,424,384.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Kathleen Alyce Waters sold 11,285 shares of the firm’s stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $120.73, for a total value of $1,362,438.05. Following the completion of the transaction, the insider now directly owns 81,297 shares of the company’s stock, valued at $9,814,986.81. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 134,540 shares of company stock worth $16,551,071. Insiders own 1.40% of the company’s stock.

Hedge Funds Weigh In On DaVita

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in DaVita by 2.4% in the fourth quarter. Vanguard Group Inc. now owns 6,320,740 shares of the company’s stock worth $662,161,000 after purchasing an additional 145,711 shares in the last quarter. Invesco Ltd. raised its holdings in shares of DaVita by 21.3% in the 3rd quarter. Invesco Ltd. now owns 1,667,255 shares of the company’s stock worth $157,606,000 after buying an additional 292,767 shares in the last quarter. Deutsche Bank AG lifted its position in shares of DaVita by 421.8% during the 3rd quarter. Deutsche Bank AG now owns 1,095,081 shares of the company’s stock worth $103,518,000 after buying an additional 885,195 shares during the period. Gates Capital Management Inc. grew its position in DaVita by 3.1% in the fourth quarter. Gates Capital Management Inc. now owns 905,830 shares of the company’s stock valued at $94,895,000 after acquiring an additional 27,660 shares during the period. Finally, 8 Knots Management LLC acquired a new position in DaVita during the fourth quarter worth $89,504,000. 90.12% of the stock is owned by institutional investors.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.